Przejdź do zawartości
Merck

Przejdź do

SCM121

OsteoMAX-XF Differentiation Medium

Defined Xeno-Free osteogenesis differentiation medium that is specially formulated to readily differentiate human mesenchymal stem cells (MSCs) into mature osteocytes as assessed by alizarin red & alkaline phosphatase staining.

Synonim(y):

Osteocyte differentiation media, Osteogenesis Media, Osteogenesis media, Osteocyte differentiation media

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

Zmień widok
Gabaryty przesyłkiSKUDostępnośćCena netto
1 kit

Dostępne do wysyłki DZISIAJzKuehne + Nagel Sp. z o.o.

1470,00 zł

Informacje o tej pozycji

UNSPSC Code:
12352207
NACRES:
NA.75
eCl@ss:
32160801

1470,00 zł


Dostępne do wysyłki DZISIAJSzczegóły


Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomóc

Quality Level

form

liquid

manufacturer/tradename

OsteoMAX-XF

technique(s)

cell culture | stem cell: suitable

shipped in

dry ice

storage temp.

-10 to -25°C

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 1

Ta pozycja
SCM123SCM102SCM045
form

liquid

form

-

form

liquid

form

liquid

technique(s)

cell culture | stem cell: suitable

technique(s)

-

technique(s)

cell differentiation: suitable

technique(s)

cell culture | stem cell: suitable

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

Quality Level

100

Quality Level

-

Quality Level

100

Quality Level

300

manufacturer/tradename

OsteoMAX-XF

manufacturer/tradename

-

manufacturer/tradename

-

manufacturer/tradename

Chemicon®

General description

Bone undergoes a continual remodeling process that requires the coordinated activity of two cell types. Osteoclasts break down the bone matrix while osteoblasts deposit collagen, calcium, and phosphorous and other minerals to form new bone. The balance between the activity of osteoclasts and osteoblasts determines the mass and density of the bone. Many diseases of bone including osteoporosis, a common age-related phenomenon in post-menopausal women in which the bone mass has been greatly reduced, and osteogenesis imperfecta, also known as brittle-bone disease, are likely caused by the misregulation of osteoblasts and osteoclasts. Understanding the molecular mechanisms that underlie osteogenesis, the process by which new bone is formed is thus of critical importance.

Mesenchymal stem cells (MSC) are defined as a self-renewing population of adherent, multipotent progenitor cells with the capacity to differentiate into several mesenchymal cell lineages. MSC have been isolated from adult bone marrow, adipose tissue, and umbilical cord blood and can be generated in vitro from embryonic and induced pluripotent stem cells. In defined in vitro assays, MSC have been shown to readily differentiate into lineage-specific cells that form bone, cartilage, fat, tendon, and muscle tissues.

EMD Millipore’s OsteoMAX-XF Differentiation Medium is specially formulated to readily differentiate human mesenchymal stem cells into the osteogenic lineage (osteocytes) as assessed by alizarin red and alkaline phosphatase staining. This proprietary formulation was developed using Plasticell’s CombiCultTM, a patented, bead-based, combinatorial technology specially developed for discovery of novel stem cell differentiation protocols.

Features and Benefits
- Serum-free, xeno-free, defined medium formulation
- Rapid, robust, and highly efficient mineralization and bone nodule formation in standard tissue culture system by as early as 7 days of differentiation.

Using EMD Millipore′s OsteoMAX-XF Differentiation Media, we typically obtain 80% mature osteocytes from bone marrow derived mesenchymal stem cells. Efficiency of osteogenic differentiation may vary, depending upon the source and quality of the mesenchymal stem cells and if variations to the protocol are introduced.

Preparation Note

1. OsteoMAX-XF Basal Medium (Part No. CS210596). One bottle containing 90 mL basal medium.

2. OsteoMAX-XF Supplement (10X) (Part No. CS210597). One bottle containing 10 mL of 10X concentrated supplement.
OsteoMAX-XF Basal Medium: (Part No. CS210596) should be stored at -20°C until ready to use. Use within four months from date of receipt. Upon thawing, the medium can be kept refrigerated at 2° to 8°C in the dark for up to 6 months.

OsteoMAX-XF Supplement (10X): (Part No. CS210597) should be stored at -20°C until ready to use. Use within four months from date of receipt. Upon thawing, add the Supplement to the Basal Medium, mix thoroughly and filter sterilize using a 0.22 um stericup filter. The filtered supplemented complete media can be stored short term at 2 to 8°C in the dark and should be used within 7 days. For long term storage, aliquot the filtered supplemented complete media into appropriate working volumes and stored at -20°C. Avoid repeated freeze-thaw cycles as it will affect activity levels.
Ta strona może zawierać tekst przetłumaczony maszynowo.

Klasa składowania

12 - Non Combustible Liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

wgk

WGK 2


Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Produkty

Frequently asked questions about mesenchymal stem cells including MSC derivation, expansion, differentiation and allogenic stem cell therapy.

Development of a novel serum-free and xeno-free human mesenchymal stem cell (MSC) osteocyte differentiation media.

Highly characterized human mesenchymal stem cell lines from bone-marrow, adipose and umbilical cord along with serum-free MSC expansion and differentiation media.

Protokoły

Information about mesenchyme, specifically mesenchymal stem cell procotols. Step-by-step cell culture protocols for mesenchymal stem cell (MSC) isolation, expansion and differentiation.

Informacje na temat mezenchymy, w szczególności protokołów mezenchymalnych komórek macierzystych. Protokoły hodowli komórkowej krok po kroku do izolacji, ekspansji i różnicowania mezenchymalnych komórek macierzystych (MSC).

Numer pozycji handlu globalnego

SKUNUMER GTIN
SCM12104053252847899

Questions

  1. Hi, can it be used for O9-1 Mouse Cranial Neural Crest Cell Line differentiation? Thank you.

    1 answer
    1. EMD Millipore’s OsteoMAX-XF™ Differentiation Medium is formulated to readily differentiate human mesenchymal stem cells into the osteogenic lineage. We have not tested it for O9-1 Mouse Cranial Neural Crest Cell Line differentiation.

      Helpful?

Reviews

No rating value

Active Filters

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej